Types of addiction treatment
Extended-release buprenorphine (BUP-XR) therapy has become an important treatment option for individuals with opioid use disorder by providing long-lasting medication delivery that helps reduce cravings, prevent withdrawal symptoms, and support recovery. Because BUP-XR is administered as a subcutaneous injection by a healthcare professional, some patients may have concerns about injection-related discomfort and whether local anesthesia … Read more
Mental health conditions and substance use disorders affect millions of people worldwide, yet many individuals struggle to obtain the medications that could significantly improve their health, stability, and quality of life. Effective treatments are available for conditions such as depression, anxiety, bipolar disorder, schizophrenia, alcohol use disorder, and opioid use disorder, but access is often … Read more
Medicaid plays a vital role in the United States healthcare system by providing access to essential mental health and substance use disorder (SUD) services for millions of individuals. Mental illness and addiction can significantly impact a person’s physical health, relationships, employment, and overall quality of life, making access to affordable treatment critically important. As one … Read more
Addiction medicine is a specialized field of healthcare dedicated to preventing, diagnosing, and treating substance use disorders through evidence-based, patient-centered care. Recognizing addiction as a chronic but treatable medical condition, addiction medicine combines medications, behavioral therapies, mental health care, and long-term recovery support to address the physical, psychological, and social aspects of the disease. Rather … Read more
Mobile addiction treatment programs are expanding access to evidence-based care by delivering healthcare services directly to people in their communities. Operating from specially equipped vans or mobile clinics, these programs offer medical assessments, medications for opioid use disorder, counseling, mental health screenings, overdose prevention education, and referrals to additional health and social services. By overcoming … Read more
Nitazenes are a group of highly potent synthetic opioids that have emerged as a growing public health concern due to their increasing presence in the illicit drug supply. Originally developed decades ago for research purposes but never approved for medical use, these substances can be significantly more potent than fentanyl, depending on the specific compound. … Read more
GLP-1 receptor agonists, including medications such as semaglutide and liraglutide, have transformed the treatment of type 2 diabetes and obesity by improving blood sugar control and promoting weight loss. More recently, researchers have begun exploring their effects on the brain, particularly in areas involved in reward processing, impulse control, emotional regulation, and decision-making. Early studies … Read more
Psychedelic-assisted therapy has emerged as one of the most closely studied innovations in mental health treatment for people living with post-traumatic stress disorder (PTSD) and depression. Researchers are investigating whether medications such as psilocybin and MDMA, when administered in carefully controlled clinical settings alongside psychotherapy, can help individuals process traumatic experiences, reduce depressive symptoms, and … Read more
Alcohol use disorder (AUD) and food addiction are complex conditions that share many similarities in brain function, behavior, and emotional regulation. Although food addiction is not currently recognized as an official diagnosis in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), research suggests that some highly processed foods rich in sugar, refined carbohydrates, fat, … Read more
The illicit drug supply continues to evolve, creating new dangers for individuals with opioid use disorder and for the healthcare professionals who treat them. One emerging concern is the presence of medetomidine, a potent veterinary sedative, mixed with illegally manufactured fentanyl. Like xylazine, medetomidine is an alpha-2 adrenergic agonist that is not approved for human … Read more